Skip to main content
logo
Keymed Biosciences Inc. (HKG:2162)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
77.75
+0.70 (0.91%)
Aug 20, 2026, 4:09 PM HKT

Keymed Biosciences Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
22,90515,7468,51613,58614,1749,651
Market Cap Growth
4.01%84.90%-37.32%-4.15%46.87%-
Enterprise Value
19,98513,6396,52610,72510,33115,170
Last Close Price
77.7553.4530.9049.1051.0034.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
23.7719.7518.6934.83125.3071.30
PB Ratio
4.955.103.234.133.762.16
P/TBV Ratio
4.975.123.254.133.762.15

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
20.7417.1114.3227.4991.33112.08

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.170.280.300.140.040.01
Net Debt / Equity Ratio
-0.63-0.41-0.57-0.77-0.91-0.96
Net Debt / EBITDA Ratio
4.242.072.555.675.8510.02
Net Debt / FCF Ratio
-1.091.413.374.499.02
Asset Turnover
0.160.180.110.090.030.05
Inventory Turnover
0.870.530.130.660.071.02
Quick Ratio
4.212.493.048.808.4531.55
Current Ratio
4.832.903.309.368.7231.96
Return on Equity (ROE)
21.49%-19.91%-18.85%-11.31%-8.69%-305.24%
Return on Assets (ROA)
-8.24%-9.88%-10.23%-7.32%-8.65%-10.09%
Return on Capital Employed (ROCE)
-14.00%-18.70%-20.70%-12.80%-15.30%-9.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
3.90%-3.69%-6.44%-2.91%-2.46%-49.44%
FCF Yield
--7.40%-12.46%-5.53%-5.43%-4.92%
Buyback Yield / Dilution
-8.53%-4.59%-0.22%-0.09%-62.34%-139.72%